Kynam Capital Management LP grew its holdings in shares of Celldex Therapeutics, Inc. ( NASDAQ:CLDX – Get Rating ) by 16.1% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,600,127 shares of the biopharmaceutical company's stock after acquiring an additional 221,468 shares during the quarter. Celldex Therapeutics accounts for approximately 9.5% of Kynam Capital Management LP's holdings, making the stock its 3rd biggest holding.

https://www.dailypolitical.com/2023/03/05/kynam-capital-management-lp-raises-stock-holdings-in-celldex-therapeutics-inc-nasdaqcldx.html

#dailypolitical